155 related articles for article (PubMed ID: 38769830)
1. [Application and Research Progress of Lung Cancer Organoid in Precision Medicine
for Lung Cancer].
Huang Z; Li B; Wang Y; Xue J; Wei Z; Liang N; Li S
Zhongguo Fei Ai Za Zhi; 2024 Apr; 27(4):276-282. PubMed ID: 38769830
[TBL] [Abstract][Full Text] [Related]
2. [Application of Organoids in Lung Cancer Precision Medicine].
Jia Z; Liang N; Li S
Zhongguo Fei Ai Za Zhi; 2020 Jul; 23(7):615-620. PubMed ID: 32702796
[TBL] [Abstract][Full Text] [Related]
3. Patient-derived organoids in human cancer: a platform for fundamental research and precision medicine.
Qu S; Xu R; Yi G; Li Z; Zhang H; Qi S; Huang G
Mol Biomed; 2024 Feb; 5(1):6. PubMed ID: 38342791
[TBL] [Abstract][Full Text] [Related]
4. Using patient-derived organoids to predict locally advanced or metastatic lung cancer tumor response: A real-world study.
Wang HM; Zhang CY; Peng KC; Chen ZX; Su JW; Li YF; Li WF; Gao QY; Zhang SL; Chen YQ; Zhou Q; Xu C; Xu CR; Wang Z; Su J; Yan HH; Zhang XC; Chen HJ; Wu YL; Yang JJ
Cell Rep Med; 2023 Feb; 4(2):100911. PubMed ID: 36657446
[TBL] [Abstract][Full Text] [Related]
5. A dual-functional microfluidic chip for guiding personalized lung cancer medicine: combining EGFR mutation detection and organoid-based drug response test.
Zhang K; Xi J; Zhao H; Wang Y; Xue J; Liang N; Wei Z
Lab Chip; 2024 Mar; 24(6):1762-1774. PubMed ID: 38352981
[TBL] [Abstract][Full Text] [Related]
6. Applications of lung cancer organoids in precision medicine: from bench to bedside.
Li H; Chen Z; Chen N; Fan Y; Xu Y; Xu X
Cell Commun Signal; 2023 Dec; 21(1):350. PubMed ID: 38057851
[TBL] [Abstract][Full Text] [Related]
7. Ex vivo drug testing of patient-derived lung organoids to predict treatment responses for personalized medicine.
Taverna JA; Hung CN; Williams M; Williams R; Chen M; Kamali S; Sambandam V; Hsiang-Ling Chiu C; Osmulski PA; Gaczynska ME; DeArmond DT; Gaspard C; Mancini M; Kusi M; Pandya AN; Song L; Jin L; Schiavini P; Chen CL
Lung Cancer; 2024 Apr; 190():107533. PubMed ID: 38520909
[TBL] [Abstract][Full Text] [Related]
8. Deciphering the Tumor Microenvironment of Colorectal Cancer and Guiding Clinical Treatment With Patient-Derived Organoid Technology: Progress and Challenges.
Li J; Liu J; Xia W; Yang H; Sha W; Chen H
Technol Cancer Res Treat; 2024; 23():15330338231221856. PubMed ID: 38225190
[TBL] [Abstract][Full Text] [Related]
9. Tumor organoids: applications in cancer modeling and potentials in precision medicine.
Xu H; Jiao D; Liu A; Wu K
J Hematol Oncol; 2022 May; 15(1):58. PubMed ID: 35551634
[TBL] [Abstract][Full Text] [Related]
10. Organoids: approaches and utility in cancer research.
Zhou B; Feng Z; Xu J; Xie J
Chin Med J (Engl); 2023 Aug; 136(15):1783-1793. PubMed ID: 37365679
[TBL] [Abstract][Full Text] [Related]
11. Cancer organoid co-culture model system: Novel approach to guide precision medicine.
Yuan J; Li X; Yu S
Front Immunol; 2022; 13():1061388. PubMed ID: 36713421
[TBL] [Abstract][Full Text] [Related]
12. Progress and perspective of organoid technology in cancer-related translational medicine.
Lin Y; Jiang L; He Q; Yuan M; Cao J
Biomed Pharmacother; 2022 May; 149():112869. PubMed ID: 35358798
[TBL] [Abstract][Full Text] [Related]
13. Unlocking the potential of organoids in cancer treatment and translational research: An application of cytologic techniques.
Abd El-Salam MA; Troulis MJ; Pan CX; Rao RA
Cancer Cytopathol; 2024 Feb; 132(2):96-102. PubMed ID: 37843532
[TBL] [Abstract][Full Text] [Related]
14. Scientific Validation and Clinical Application of Lung Cancer Organoids.
Lee D; Kim Y; Chung C
Cells; 2021 Nov; 10(11):. PubMed ID: 34831235
[TBL] [Abstract][Full Text] [Related]
15. Liver organoids: a promising three-dimensional model for insights and innovations in tumor progression and precision medicine of liver cancer.
Chen Y; Liu Y; Chen S; Zhang L; Rao J; Lu X; Ma Y
Front Immunol; 2023; 14():1180184. PubMed ID: 37334366
[TBL] [Abstract][Full Text] [Related]
16. Circulating tumor cell-derived organoids: Current challenges and promises in medical research and precision medicine.
Praharaj PP; Bhutia SK; Nagrath S; Bitting RL; Deep G
Biochim Biophys Acta Rev Cancer; 2018 Apr; 1869(2):117-127. PubMed ID: 29360544
[TBL] [Abstract][Full Text] [Related]
17. Application of Cancer Organoid Model for Drug Screening and Personalized Therapy.
Kondo J; Inoue M
Cells; 2019 May; 8(5):. PubMed ID: 31108870
[TBL] [Abstract][Full Text] [Related]
18. Organoid technology in cancer precision medicine.
Xia X; Li F; He J; Aji R; Gao D
Cancer Lett; 2019 Aug; 457():20-27. PubMed ID: 31078736
[TBL] [Abstract][Full Text] [Related]
19. Organoid technology and applications in cancer research.
Xu H; Lyu X; Yi M; Zhao W; Song Y; Wu K
J Hematol Oncol; 2018 Sep; 11(1):116. PubMed ID: 30219074
[TBL] [Abstract][Full Text] [Related]
20. Challenges in Establishing Pure Lung Cancer Organoids Limit Their Utility for Personalized Medicine.
Dijkstra KK; Monkhorst K; Schipper LJ; Hartemink KJ; Smit EF; Kaing S; de Groot R; Wolkers MC; Clevers H; Cuppen E; Voest EE
Cell Rep; 2020 May; 31(5):107588. PubMed ID: 32375033
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]